• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

68Ga-DOTATATE PET/CT 显示复发性/残留颅内成纤维细胞磷酸盐肿瘤。

Recurrent/Residual Intracranial Phosphaturic Mesenchymal Tumor Revealed on 68Ga-DOTATATE PET/CT.

机构信息

From the Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing; and Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Beijing, China.

出版信息

Clin Nucl Med. 2018 Sep;43(9):674-675. doi: 10.1097/RLU.0000000000002205.

DOI:10.1097/RLU.0000000000002205
PMID:30015664
Abstract

Phosphaturic mesenchymal tumors are benign tumors causing majority of tumor-induced osteomalacia. These tumors are most commonly located in the lower extremities followed by craniofacial regions. However, intracranial lesion is very rare. Here we describe Ga-DOTATATE PET/CT findings of a recurrent intracranial phosphaturic mesenchymal tumor in a 68 year old woman.

摘要

磷酸化解质肿瘤是良性肿瘤,引起大多数肿瘤相关性骨软化症。这些肿瘤最常发生于下肢,其次是颅面部。然而,颅内病变非常罕见。在此,我们描述了一位 68 岁女性复发性颅内磷酸化解质肿瘤的 Ga-DOTATATE PET/CT 表现。

相似文献

1
Recurrent/Residual Intracranial Phosphaturic Mesenchymal Tumor Revealed on 68Ga-DOTATATE PET/CT.68Ga-DOTATATE PET/CT 显示复发性/残留颅内成纤维细胞磷酸盐肿瘤。
Clin Nucl Med. 2018 Sep;43(9):674-675. doi: 10.1097/RLU.0000000000002205.
2
Comparison of F-FDG PET/CT and Ga-DOTATATE PET/CT in the Targeted Imaging of Culprit Tumors Causing Osteomalacia.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描与镓- DOTATATE 正电子发射断层扫描/计算机断层扫描在致佝偻病罪犯肿瘤靶向成像中的比较。
Orthop Surg. 2021 May;13(3):791-798. doi: 10.1111/os.12980. Epub 2021 Mar 11.
3
Lung Nodule as Culprit Lesion Causing Recurrent Tumor-Induced Osteomalacia Revealed by 68 Ga-DOTATATE PET/CT.68Ga-DOTATATE PET/CT 显示肺结节为复发性肿瘤相关性骨软化症的责任病灶
Clin Nucl Med. 2023 Sep 1;48(9):826-827. doi: 10.1097/RLU.0000000000004771. Epub 2023 Jul 22.
4
177Lu-DOTATATE PRRT in Recurrent Skull-Base Phosphaturic Mesenchymal Tumor Causing Osteomalacia: A Potential Application of PRRT Beyond Neuroendocrine Tumors.177Lu-DOTATATE肽受体放射性核素治疗复发性导致骨软化症的颅底磷酸尿性间叶肿瘤:肽受体放射性核素治疗在神经内分泌肿瘤之外的潜在应用
J Nucl Med Technol. 2016 Dec;44(4):248-250. doi: 10.2967/jnmt.116.177873. Epub 2016 Sep 15.
5
Comparison of 18F-FDG and 68Ga DOTATATE PET/CT in localization of tumor causing oncogenic osteomalacia.18F-FDG 和 68Ga-DOTATATE PET/CT 对肿瘤致成瘤性骨软化症定位的比较。
Clin Nucl Med. 2015 Jan;40(1):e6-e10. doi: 10.1097/RLU.0000000000000460.
6
[Value of Ga-DOTA-TATE Positron Emission Tomography/Computed Tomography in the Localization of Culprit Tumors Causing Osteomalacia with Negative Tc-HYNIC-TOC Single Photo Emission Computed Tomography].[镓-多柔比星-奥曲肽正电子发射断层扫描/计算机断层扫描在Tc-HYNIC-TOC单光子发射计算机断层扫描阴性的骨软化症致病肿瘤定位中的价值]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2018 Dec 20;40(6):757-764. doi: 10.3881/j.issn.1000-503X.10693.
7
Intracranial Phosphaturic Mesenchymal Tumor Detected by 68 Ga-DOTATATE PET/CT.颅内磷酸化解质肿瘤经 68Ga-DOTATATE PET/CT 检测。
Clin Nucl Med. 2024 May 1;49(5):459-461. doi: 10.1097/RLU.0000000000005066. Epub 2024 Jan 24.
8
Ga-DOTATATE positron emission tomography/computed tomography to detect the recurrence of phosphaturic mesenhcymal tumor-induced osteomalacia.镓- DOTATATE正电子发射断层扫描/计算机断层扫描用于检测磷尿性间叶肿瘤诱导的骨软化症的复发。
World J Nucl Med. 2019 Jul 23;19(1):78-81. doi: 10.4103/wjnm.WJNM_92_18. eCollection 2020 Jan-Mar.
9
Utility of 18F-AlF-NOTA-Octreotide PET/CT in the Localization of Tumor-Induced Osteomalacia.18F-AlF-NOTA-Octreotide PET/CT 在肿瘤相关性骨软化症定位中的应用。
J Clin Endocrinol Metab. 2021 Sep 27;106(10):e4202-e4209. doi: 10.1210/clinem/dgab258.
10
Ga-DOTATATE for Tumor Localization in Tumor-Induced Osteomalacia.镓-多柔比星用于肿瘤性骨软化症的肿瘤定位
J Clin Endocrinol Metab. 2016 Oct;101(10):3575-3581. doi: 10.1210/jc.2016-2052. Epub 2016 Aug 17.

引用本文的文献

1
Intracranial phosphaturic mesenchymal tumor: A rare case report and systematic review.颅内磷酸尿性间叶性肿瘤:一例罕见病例报告及系统综述
Medicine (Baltimore). 2025 Feb 21;104(8):e41623. doi: 10.1097/MD.0000000000041623.
2
Phosphaturic Mesenchymal Tumors: Rethinking the Clinical Diagnosis and Surgical Treatment.磷酸尿性间叶肿瘤:对临床诊断与外科治疗的重新思考
J Clin Med. 2022 Dec 29;12(1):252. doi: 10.3390/jcm12010252.
3
Tumour-induced osteomalacia due to a durally-based intracranial phosphaturic mesenchymal tumour.因硬脊膜内致磷质尿性间叶肿瘤导致的肿瘤相关性骨软化症。
BMJ Case Rep. 2022 Nov 1;15(11):e252412. doi: 10.1136/bcr-2022-252412.
4
Persistence and recurrence in tumor-induced osteomalacia: A systematic review of the literature and results from a national survey/case series.肿瘤性骨软化症中的持续性和复发性:文献系统综述及全国调查/病例系列研究结果。
Endocrine. 2022 Jun;76(3):709-721. doi: 10.1007/s12020-022-03039-2. Epub 2022 Apr 5.
5
Clinical Applications of Somatostatin Receptor (Agonist) PET Tracers beyond Neuroendocrine Tumors.生长抑素受体(激动剂)PET示踪剂在神经内分泌肿瘤以外的临床应用
Diagnostics (Basel). 2022 Feb 18;12(2):528. doi: 10.3390/diagnostics12020528.
6
Extended Whole-body Ga-68 DOTATATE PET-CT in evaluating Tumour-Induced Osteomalacia: Case report and review of literature.镓-68 DOTATATE 全身PET-CT在评估肿瘤诱导的骨软化症中的应用:病例报告及文献复习
Nucl Med Mol Imaging. 2021 Jun;55(3):130-135. doi: 10.1007/s13139-021-00695-6. Epub 2021 Apr 19.